Skip to main content

Advertisement

Table 1 Association between potential risk factors and HSV detected in CVL

From: Detection, quantification and genotyping of Herpes Simplex Virus in cervicovaginal secretions by real-time PCR: a cross sectional survey

Cofactors Present Absent Relative risk (95% CI) P-value
GUD 2/5 (40%) 25/65 (38%) 1.04 (0.34 – 3.18) 0.68
Anti HSV-2 IgG* (Kalon test) 11/27 (41%) 7/32 (22%) 1.86 (0.84 – 4.13) 0.19
HIV 3/7 (43%) 23/59 (39%) 1.1 (0.44 – 2.74) 0.83
BV 14/35 (40%) 13/35 (37%) 1.08 (0.60 – 1.95) 1.00
C. trachomatis 5/7 (71%) 22/63 (35%) 2.05 (1.15 – 3.64) 0.14
Hepatitis B 5/8 (63%) 22/54 (41%) 1.53 (0.82 – 2.87) 0.44
Candida 9/29 (31%) 18/41 (44%) 0.71 (0.37 – 1.35) 0.40
T. vaginalis 3/7 (43%) 24/63 (38%) 1.13 (0.45 – 2.80) 0.86
  1. * Comparison with HSV-2 only. P values calculated by χ2 test